Introduction
Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established treatment for complications of portal hypertension in cirrhotic patients.With an artificial shunt created between the portal vein and the hepatic vein, part of the portal vein blood flows directly into the inferior vena cava through the shunt, reducing the portal pressure. The hemodynamic changes after TIPS may have particularly unfavorable effects on hepatic perfusion and function. Liver volume is significantly correlated with liver function, and post-TIPS liver atrophy and dysfunction associated with poor prognosis have been reported. However, the spatial heterogeneity of segmental liver shrinkage and predictors affecting liver volume remain poorly characterized. The volume and function changes of spleen and kidney secondary to portal decompression after TIPS also deserve further investigation.
Aims & Methods
This study aimed to provide a comprehensive description of liver volume remodeling and multiorgan interactions after TIPS and analyze the related factors. Clinical data of patients who underwent TIPS procedures between January 2022 and December 2024 were collected and analyzed retrospectively. Three-dimensional CT volumetry was performed to quantify whole-liver, segmental (S1–S8), splenic, and bilateral kidney volumes before and 6 months after TIPS using the SenseCare® Liver CT. The changes in liver volume after TIPS were analyzed, and the independent predictors affecting liver volume were identified using a multivariable logistic regression model. The changes in spleen and kidney volumes after TIPS and their correlations with laboratory parameters were also analyzed.
Results
A total of 99 patients were included in the study. The median portal pressure gradient decreased from 19.0 (17.0, 21.0) mmHg to 9.0 (7.0, 10.0) mmHg (P<0.001) after the TIPS procedure. Following TIPS, the volume of the whole liver decreased significantly compared with the baseline [median volume: 822.1 (669.8, 1020.6) cm³ vs. 1113.8 (920.7, 1286.1) cm³, P<0.001]. The right lobe showed greater atrophy than the left lobe (median change rate: -24.2% vs. -19.3%, P=0.046), with segment S3 exhibiting the most pronounced reduction (P<0.001). Moreover, the spleen volume significantly decreased (median volume: 663.0 (471.6, 966.2) cm³ vs. 800.5 (621.8, 1135.6) cm³, P<0.001), while bilateral kidney volumes significantly increased (both P<0.001) after surgery. Multivariate regression analysis identified stent diameter (8 mm vs. non-8 mm: B=-11.68, P=0.007) and HBV etiology (B=-5.44, P=0.043) as independent predictors of greater liver atrophy. Furthermore, volumetric changes in organ morphology were closely related to the function alterations. Greater liver shrinkage was significantly correlated with a more pronounced elevation in postoperative total bilirubin, INR, and MELD score (r=-0.383 to -0.408, all P<0.05). The extent of spleen reduction was significantly correlated with the increase in peripheral white blood cell count (r=-0.401, P<0.001), and the degree of kidney enlargement showed a significant correlation with the postoperative decrease in serum creatinine levels (r=-0.259, P=0.012).
Conclusion
TIPS induces spatially heterogeneous liver atrophy (right > left, S3 most severe), which is modulated by stent diameter and etiology. The multiorgan remodeling—liver shrinkage, spleen reduction, and kidney enlargement—is functionally linked to key laboratory changes, highlighting the systemic hemodynamic and functional consequences after TIPS.
References
None